Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7606 AL 7620

Application of carbon-based nanomaterials in Alzheimer's disease

Bai M, Shao X, Wang C, Wang J, Wang X, Guan P, Hu X.

Mater Horiz. 2025 Feb 3;12(3):673-693. doi: 10.1039/d4mh01256a.

The Contribution of the Renin-Angiotensin System to Alzheimer's Disease

Güzel Ö, Kehoe PG.

Curr Top Behav Neurosci. 2025;69:107-127. doi: 10.1007/7854_2024_525.

Exploring DPP IV inhibitors for Alzheimer's disease: Bridging diabetes and neurodegeneration

Pattanaik S, Prusty SK, Sahu PK.

Brain Res. 2025 Feb 1;1848:149342. doi: 10.1016/j.brainres.2024.149342. Epub 2024 Nov 19.

Calcium balance through mutual orchestrated inter-organelle communication: A pleiotropic target for combating Alzheimer's disease

Hossain MK, Chae HJ.

Neurochem Int. 2025 Jan;182:105905. doi: 10.1016/j.neuint.2024.105905. Epub 2024 Nov 19.

Recent advances in Alzheimer's disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein

Antony D, Sheth P, Swenson A, Smoller C, Maguire K, Grossberg G.

Expert Opin Pharmacother. 2025 Jan;26(1):63-73. doi: 10.1080/14656566.2024.2438317. Epub 2024 Dec 4.

Advances in the structural modification of Alzheimer's disease drug - Huperzine A

Zhu X, Xu JB, Gao F, Wan LX.

Bioorg Chem. 2025 Jan;154:108012. doi: 10.1016/j.bioorg.2024.108012. Epub 2024 Nov 29.

Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond

Sandhof CA, Murray HFB, Silva MC, Haggarty SJ.

Neurotherapeutics. 2025 Apr;22(3):e00499. doi: 10.1016/j.neurot.2024.e00499. Epub 2024 Dec 4.

Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective

Pal C.

Biochim Biophys Acta Mol Basis Dis. 2025 Mar;1871(3):167617. doi: 10.1016/j.bbadis.2024.167617. Epub 2024 Dec 8.

Neuroinflammation in Alzheimer disease

Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, Brosseron F, Teunissen C, Zetterberg H, Jacobs AH, Edison P, Ramirez A, Cruchaga C, Lambert JC, Laza AR, Sanchez-Mut JV, Fischer A, Castro-Gomez S, Stein TD, Kleineidam L, Wagner M, Neher JJ, Cunningham C, Singhrao SK, Prinz M, Glass CK, Schlachetzki JCM, Butovsky O, Kleemann K, De Jaeger PL, Scheiblich H, Brown GC, Landreth G, Moutinho M, Grutzendler J, Gomez-Nicola D, McManus RM, Andreasson K, Ising C, Karabag D, Baker DJ, Liddelow SA, Verkhratsky A, Tansey M, Monsonego A, Aigner L, Dorothée G, Nave KA, Simons M, Constantin G, Rosenzweig N, Pascual A, Petzold GC, Kipnis J, Venegas C, Colonna M, Walter J, Tenner AJ, O'Banion MK, Steinert JR, Feinstein DL, Sastre M, Bhaskar K, Hong S, Schafer DP, Golde T, Ransohoff RM, Morgan D, Breitner J, Mancuso R, Riechers SP.

Nat Rev Immunol. 2025 May;25(5):321-352. doi: 10.1038/s41577-024-01104-7. Epub 2024 Dec 9.

Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment

Tripathi S, Sharma Y, Kumar D.

Protein Pept Lett. 2025;32(1):2-17. doi: 10.2174/0109298665348075241121071614.

Intranasal amyloid model of Alzheimer's disease - potential opportunities and challenges

Singh RK.

Pharmacol Rep. 2025 Apr;77(2):425-433. doi: 10.1007/s43440-024-00692-4. Epub 2025 Jan 8.

Advancements in nose-to-brain drug targeting for Alzheimer's disease: a review of nanocarriers and clinical insights

Komal K, Ghosh R, Sil D, Sharma R, Kumar S, Pandey P, Kumar M.

Inflammopharmacology. 2025 Feb;33(2):605-626. doi: 10.1007/s10787-024-01636-3. Epub 2025 Jan 7.

Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease

Xu F, Shi J.

J Alzheimers Dis. 2025 Feb;103(4):994-1004. doi: 10.1177/13872877241307404. Epub 2025 Jan 10.

Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer's Disease

Li W, Chen Q, Peng C, Yang D, Liu S, Lv Y, Jiang L, Xu S, Huang L.

Int J Mol Sci. 2025 Jan 5;26(1):403. doi: 10.3390/ijms26010403.

Progress in the study of anti-Alzheimer's disease activity of pyrimidine-containing bioactive molecules

Liu YL, Zhang Q, Li BQ, Zhang D, Chui RH, Zhang LL, Zhang Q, Ma LY.

Eur J Med Chem. 2025 Mar 5;285:117199. doi: 10.1016/j.ejmech.2024.117199. Epub 2025 Jan 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias